Cutaneous Lupus Erythematosus: Diagnosis, Classification, and Screening for Systemic Disease

The presentation focuses on cutaneous lupus erythematosus (CLE), highlighting its clinical relevance, diagnosis, and evaluation for potential systemic involvement. The presenter discusses the classification of various CLE subtypes and the distinctive histopathological features that differentiate lupus specific skin diseases from lupus nonspecific ones. Key statistics indicate that the incidence of cutaneous lupus is comparable to systemic lupus, making it a common condition in clinical practice. The presentation covers several types of cutaneous lupus, such as discoid lupus, subacute cutaneous lupus, and lupus chilblains, and emphasizes the importance of clinical examination and biopsy in diagnosis.



The speaker also addresses the relationship between lupus and certain medications, particularly those linked to subacute cutaneous lupus, highlighting the need for thorough patient medication reviews. Important diagnostic criteria from the American College of Rheumatology and the European League Against Rheumatism for systemic lupus are outlined, along with laboratory evaluations, including urinalysis and autoimmune tests.



Monitoring for systemic progression in patients with CLE is discussed, revealing that a minority may develop systemic lupus with typically mild manifestations. The importance of clinical-pathologic correlation is underscored, along with risk factors for progression, such as positive ANA tests or generalized discoid lesions. The presentation concludes by stressing the need for increased vigilance in monitoring patients with lupus, particularly those presenting with specific skin manifestations, while also acknowledging the lack of consensus guidelines on management strategies.